Company Filing History:
Years Active: 2011-2012
Title: Innovations by Thomas Fachinger in the Field of Chemical Compounds
Introduction
Thomas Fachinger, an accomplished inventor based in Niederheimbach, Germany, has made significant contributions to the field of chemistry through his innovative research and patents. With a total of three patents to his name, Fachinger's work focuses on developing processes for synthesizing compounds that hold promise for medical applications, particularly in treating tumoral diseases.
Latest Patents
Fachinger's latest patents include a groundbreaking preparation process for compounds of specific chemical formulas. One of these innovations is a method for preparing aminocrotonylamino-substituted quinazoline derivatives. This improved process allows for the creation of quinazoline derivatives that act as inhibitors of signal transduction mediated by tyrosine kinases and the Epidermal Growth Factor Receptor (EGF-R). The implications of these compounds are critical for advancing treatments in oncology, showcasing Fachinger's focus on impactful medical solutions.
Career Highlights
Currently, Thomas Fachinger is employed at Boehringer Ingelheim International GmbH, a global leader in the pharmaceutical industry. His career, marked by a commitment to innovation, reflects his expertise in chemical research and development. The significance of his work is evident through the patents he has secured, highlighting his contributions to the advancement of medicinal chemistry.
Collaborations
Fachinger's success is also attributed to his collaborations with esteemed professionals in the field. Notable coworkers, Svenja Renner and Juergen Schroeder, have collaborated with him on various projects, fostering an environment of innovation and shared knowledge within the workplace. Together, they contribute to the strong research culture at Boehringer Ingelheim, pushing the boundaries of pharmaceutical science.
Conclusion
In summary, Thomas Fachinger stands out as a dedicated inventor in the realm of chemical compounds. His patents not only reflect his innovative spirit but also pave the way for advancements in the treatment of critical health conditions. As a valuable member of the team at Boehringer Ingelheim International GmbH, Fachinger continues to influence the field with his groundbreaking research and collaborative efforts.